Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2026-03-20

FDA Approved: EPIPEN — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approves a supplemental application for EPIPEN (epinephrine) by Viatris Specialty LLC, indicating changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EpiPen (epinephrine)

Snippet

SUPPL AP for EPIPEN (EPINEPHRINE)